These excerpts taken from the ALTH 10-K filed Feb 27, 2008 ... we completed an Initial Public Offering of 5,000,000 shares of our common stock at a price of $18.00 per share (the "IPO"). Proceeds to us from the …
Sales of the drug could reach $300 million in the US, but even if the final tally’s only $150 million, that still adds up to about $5 a share for the stock. And ALTH closed Thursday at $5.89. The stock took a hit as a result of …
Short float at 11.41%, which implies a short ratio of 7.14 days. The stock has lost -10.89% over the last year. 10. Allos Therapeutics, Inc. (ALTH): Drug Manufacturers - Other Industry. Market cap of $351.87M. The stock is …
NASDAQ
We see limited upside potential until Allos is successful in expanding its product portfolio. The stock carries a Zacks #3 Rank (Hold rating) in the short-run. Read the Full Research Report on ALTH Zacks Investment …
Currently, Allos Therapeutics’ (ALTH) Folotyn is the only FDA approved drug for treating ... which is supported by our Zacks # 3 Rank (short-term ‘Hold’ recommendation) on the stock. ZIOPHARM Oncology Inc (ZIOP) - free …
Sign Up for our Free Stock Newsletter. Stout is also on the boards at Allos Therapeutics Inc. (NASDAQ: ALTH), Jabil Circuit Inc. (NYSE: JBL) and Airgas Inc. (NYSE: ARG). Sign up for the free Best Damn Penny Stocks …
May 25 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH) is disclosing the following information about a grant of restricted stock awarded to Paul L. Berns as an inducement to his entering into employment …
BOSTON (MarketWatch) -- Shares of AMAG Pharmaceuticals AMAG, -0.23% dropped 14% to $16.46 on Wednesday following news that it plans to merge with Allos Therapeutics alth in an all-stock deal valued at …
The trader received a net credit of 7 cents per contract, which he will retain in full as long as shares of ALTH remain higher than $5 by expiration. Additional profits would be realized in the event that the stock rallies 33% …
New England area biotechs had news this week on stock price, clinical data ... with its shareholders recently …